Study on Sotrovimab and Its Impact on the Immune Response to COVID-19 Infection in Real-life in the UAE and Bahrain

Last updated: May 30, 2022
Sponsor: Abu Dhabi Health Services Company
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Treatment

N/A

Clinical Study ID

NCT05398718
Abu Dhabi Health Services
  • Ages > 12
  • All Genders

Study Summary

The United Arab Emirates (UAE), the Kingdom of Bahrain, Kuwait, Oman, and Qatar have authorised sotrovimab for emergency use. Local experience among physicians include recent successful COVID-19 vaccine pivotal studies supported by the authorities' willingness to expedite understanding of the role of monoclonal antibodies such as sotrovimab in the management of COVID-19 and expertise to integrate the latest knowledge into the local or regional COVID-19 management guidelines. The aim of this study is to collect local clinical evidence for sotrovimab effect in the real-life setting in the UAE and the Kingdom of Bahrain. Overall study population is 20,000 and the duration of the study will be approximately six months from recruitment date.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults and paediatric patients (≥ 12 years of age weighing at least 40 kg)
  • Mild-to-moderate COVID-19
  • Positive results of direct SARS-CoV-2 viral testing
  • High risk for progression to severe COVID-19

Exclusion

Exclusion Criteria:

  • Patients who are hospitalised due to COVID-19 before sotrovimab administration
  • Patients who require oxygen therapy due to COVID-19 before sotrovimab administrationoPatients who received pharmacological treatment including monoclonal antibodies toany components of SARS-CoV-2 virus within 6 months prior to enrolment into the studyin retrospective and prospective arms.

Study Design

Total Participants: 20000
Study Start date:
May 12, 2022
Estimated Completion Date:
December 31, 2022

Connect with a study center

  • The National Taskforce for combating COVID-19, Royal Medical Services.

    Manama,
    Bahrain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.